Overview

Safety and Efficacy of Sequential Therapy With Mexidol in Patients With Chronic Cerebral Ischemia

Status:
COMPLETED
Trial end date:
2020-12-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and efficacy of sequential treatment with Mexidol in patients with chronic cerebral ischemia (CCI).
Phase:
PHASE3
Details
Lead Sponsor:
Pharmasoft
Treatments:
emoxypine succinate
ethylmethylhydroxypyridine succinate